Filing Details
- Accession Number:
- 0000315066-13-003356
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-06-21 19:58:57
- Reporting Period:
- 2013-06-19
- Filing Date:
- 2013-06-21
- Accepted Time:
- 2013-06-21 19:58:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1104506 | Insmed Inc | INSM | Pharmaceutical Preparations (2834) | 541972729 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 315066 | Fmr Llc | 245 Summer Street Boston MA 02210 | No | No | Yes | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-06-19 | 42,798 | $12.47 | 1,611,427 | No | 4 | S | Indirect | by Beacon Bioventures Limited Partnership |
| Common Stock | Disposition | 2013-06-19 | 290 | $12.47 | 10,922 | No | 4 | S | Indirect | by Beacon Bioventures Principals Limited Partnership |
| Common Stock | Disposition | 2013-06-20 | 99,327 | $12.14 | 1,512,100 | No | 4 | S | Indirect | by Beacon Bioventures Limited Partnership |
| Common Stock | Disposition | 2013-06-20 | 673 | $12.14 | 10,249 | No | 4 | S | Indirect | by Beacon Bioventures Principals Limited Partnership |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | by Beacon Bioventures Limited Partnership |
| No | 4 | S | Indirect | by Beacon Bioventures Principals Limited Partnership |
| No | 4 | S | Indirect | by Beacon Bioventures Limited Partnership |
| No | 4 | S | Indirect | by Beacon Bioventures Principals Limited Partnership |
Footnotes
- The price reported for this transaction is the weighted average price of multiple trades at prices ranging from $12.2564 to $12.7772. FMR LLC hereby undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Billionaire Hedge Funds
